108 participants
PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-26
- Start Date:
- 2026-09-01
- Completion:
- 2029-03-01
Conditions
- Type 1 Diabetes (T1D)
Interventions
- DRUG
No Results Yet